Harnessing hyaluronic acid for the treatment of osteoarthritis: A bibliometric analysis
Background: Osteoarthritis (OA) is a common disease which usually occurs in middle-aged and elderly people. Hyaluronic acid (HA) has been widely used to treat OA and related researches on the efficacy and safety of HA in the treatment of OA have been published. Therefore, the purpose of this researc...
Uložené v:
| Vydané v: | Frontiers in bioengineering and biotechnology Ročník 10; s. 961459 |
|---|---|
| Hlavní autori: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Lausanne
Frontiers Media SA
09.09.2022
Frontiers Media S.A |
| Predmet: | |
| ISSN: | 2296-4185, 2296-4185 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background:
Osteoarthritis (OA) is a common disease which usually occurs in middle-aged and elderly people. Hyaluronic acid (HA) has been widely used to treat OA and related researches on the efficacy and safety of HA in the treatment of OA have been published. Therefore, the purpose of this research was to investigate the subject characteristics of harnessing HA for the treatment of OA and to analyse the relevant trends and hotspots by using a bibliometric approach.
Methods:
The articles published from 1 January 2002 to 31 December 2021 were searched in the Web of Science Core Collection (WoSCC) and the relevant information of HA for the treatment of OA was extracted after screening. Then, a total of 2438 publications were analysed by using Microsoft Excel, CiteSpace 5.8.R3, VOSviewer 1.6.18 and the Online Analysis Platform of Literature Metrology (
http://bibliometric.com/
).
Results:
A total of 2438 articles were finally included for analysis. The number of publications increased year by year. A total of 83 coutries and 3319 institutions published 2438 manuscripts in the field of use HA for the treatment of OA. The most productive country was United States with total 689 publications and
League of European Research Universities
Leru (Belgium) was the leading institution with total 126 publicatios. In terms of authors, the most prominent author was KrausVB, who published 28 papers with the highest H-index (19). In addition, Osteoarthritis and Cartilage had the highest number of publications (152 articles) and the highest number of citations (6450 citations). The co-cited references analysis indicated that the article published by McAlindon in 2014 had the most highest number of citations (91co-citations). What’s more, most research hotspots focused on the efficacy and safety of HA, and regenerative medicine researches such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) have attracted more and more attentions of researchers.
Conclusion:
This study visually analyzed the historical evolution and future trends of HA for the treatment of OA, and discussed the research priorities. At present, there are still different views on the efficacy of HA for the treatment of OA. Gradually, research hotspots of this field have focused on the regenerative medicine. |
|---|---|
| AbstractList | Background: Osteoarthritis (OA) is a common disease which usually occurs in middle-aged and elderly people. Hyaluronic acid (HA) has been widely used to treat OA and related researches on the efficacy and safety of HA in the treatment of OA have been published. Therefore, the purpose of this research was to investigate the subject characteristics of harnessing HA for the treatment of OA and to analyse the relevant trends and hotspots by using a bibliometric approach.Methods: The articles published from 1 January 2002 to 31 December 2021 were searched in the Web of Science Core Collection (WoSCC) and the relevant information of HA for the treatment of OA was extracted after screening. Then, a total of 2438 publications were analysed by using Microsoft Excel, CiteSpace 5.8.R3, VOSviewer 1.6.18 and the Online Analysis Platform of Literature Metrology (http://bibliometric.com/).Results: A total of 2438 articles were finally included for analysis. The number of publications increased year by year. A total of 83 coutries and 3319 institutions published 2438 manuscripts in the field of use HA for the treatment of OA. The most productive country was United States with total 689 publications andLeague of European Research UniversitiesLeru (Belgium) was the leading institution with total 126 publicatios. In terms of authors, the most prominent author was KrausVB, who published 28 papers with the highest H-index (19). In addition, Osteoarthritis and Cartilage had the highest number of publications (152 articles) and the highest number of citations (6450 citations). The co-cited references analysis indicated that the article published by McAlindon in 2014 had the most highest number of citations (91co-citations). What’s more, most research hotspots focused on the efficacy and safety of HA, and regenerative medicine researches such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) have attracted more and more attentions of researchers.Conclusion: This study visually analyzed the historical evolution and future trends of HA for the treatment of OA, and discussed the research priorities. At present, there are still different views on the efficacy of HA for the treatment of OA. Gradually, research hotspots of this field have focused on the regenerative medicine. Background: Osteoarthritis (OA) is a common disease which usually occurs in middle-aged and elderly people. Hyaluronic acid (HA) has been widely used to treat OA and related researches on the efficacy and safety of HA in the treatment of OA have been published. Therefore, the purpose of this research was to investigate the subject characteristics of harnessing HA for the treatment of OA and to analyse the relevant trends and hotspots by using a bibliometric approach. Methods: The articles published from 1 January 2002 to 31 December 2021 were searched in the Web of Science Core Collection (WoSCC) and the relevant information of HA for the treatment of OA was extracted after screening. Then, a total of 2438 publications were analysed by using Microsoft Excel, CiteSpace 5.8.R3, VOSviewer 1.6.18 and the Online Analysis Platform of Literature Metrology (http://bibliometric.com/). Results: A total of 2438 articles were finally included for analysis. The number of publications increased year by year. A total of 83 coutries and 3319 institutions published 2438 manuscripts in the field of use HA for the treatment of OA. The most productive country was United States with total 689 publications and League of European Research Universities Leru (Belgium) was the leading institution with total 126 publicatios. In terms of authors, the most prominent author was KrausVB, who published 28 papers with the highest H-index (19). In addition, Osteoarthritis and Cartilage had the highest number of publications (152 articles) and the highest number of citations (6450 citations). The co-cited references analysis indicated that the article published by McAlindon in 2014 had the most highest number of citations (91co-citations). What’s more, most research hotspots focused on the efficacy and safety of HA, and regenerative medicine researches such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) have attracted more and more attentions of researchers. Conclusion: This study visually analyzed the historical evolution and future trends of HA for the treatment of OA, and discussed the research priorities. At present, there are still different views on the efficacy of HA for the treatment of OA. Gradually, research hotspots of this field have focused on the regenerative medicine. Background: Osteoarthritis (OA) is a common disease which usually occurs in middle-aged and elderly people. Hyaluronic acid (HA) has been widely used to treat OA and related researches on the efficacy and safety of HA in the treatment of OA have been published. Therefore, the purpose of this research was to investigate the subject characteristics of harnessing HA for the treatment of OA and to analyse the relevant trends and hotspots by using a bibliometric approach. Methods: The articles published from 1 January 2002 to 31 December 2021 were searched in the Web of Science Core Collection (WoSCC) and the relevant information of HA for the treatment of OA was extracted after screening. Then, a total of 2438 publications were analysed by using Microsoft Excel, CiteSpace 5.8.R3, VOSviewer 1.6.18 and the Online Analysis Platform of Literature Metrology ( http://bibliometric.com/ ). Results: A total of 2438 articles were finally included for analysis. The number of publications increased year by year. A total of 83 coutries and 3319 institutions published 2438 manuscripts in the field of use HA for the treatment of OA. The most productive country was United States with total 689 publications and League of European Research Universities Leru (Belgium) was the leading institution with total 126 publicatios. In terms of authors, the most prominent author was KrausVB, who published 28 papers with the highest H-index (19). In addition, Osteoarthritis and Cartilage had the highest number of publications (152 articles) and the highest number of citations (6450 citations). The co-cited references analysis indicated that the article published by McAlindon in 2014 had the most highest number of citations (91co-citations). What’s more, most research hotspots focused on the efficacy and safety of HA, and regenerative medicine researches such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) have attracted more and more attentions of researchers. Conclusion: This study visually analyzed the historical evolution and future trends of HA for the treatment of OA, and discussed the research priorities. At present, there are still different views on the efficacy of HA for the treatment of OA. Gradually, research hotspots of this field have focused on the regenerative medicine. Background: Osteoarthritis (OA) is a common disease which usually occurs in middle-aged and elderly people. Hyaluronic acid (HA) has been widely used to treat OA and related researches on the efficacy and safety of HA in the treatment of OA have been published. Therefore, the purpose of this research was to investigate the subject characteristics of harnessing HA for the treatment of OA and to analyse the relevant trends and hotspots by using a bibliometric approach. Methods: The articles published from 1 January 2002 to 31 December 2021 were searched in the Web of Science Core Collection (WoSCC) and the relevant information of HA for the treatment of OA was extracted after screening. Then, a total of 2438 publications were analysed by using Microsoft Excel, CiteSpace 5.8.R3, VOSviewer 1.6.18 and the Online Analysis Platform of Literature Metrology (http://bibliometric.com/). Results: A total of 2438 articles were finally included for analysis. The number of publications increased year by year. A total of 83 coutries and 3319 institutions published 2438 manuscripts in the field of use HA for the treatment of OA. The most productive country was United States with total 689 publications and League of European Research Universities Leru (Belgium) was the leading institution with total 126 publicatios. In terms of authors, the most prominent author was KrausVB, who published 28 papers with the highest H-index (19). In addition, Osteoarthritis and Cartilage had the highest number of publications (152 articles) and the highest number of citations (6450 citations). The co-cited references analysis indicated that the article published by McAlindon in 2014 had the most highest number of citations (91co-citations). What's more, most research hotspots focused on the efficacy and safety of HA, and regenerative medicine researches such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) have attracted more and more attentions of researchers. Conclusion: This study visually analyzed the historical evolution and future trends of HA for the treatment of OA, and discussed the research priorities. At present, there are still different views on the efficacy of HA for the treatment of OA. Gradually, research hotspots of this field have focused on the regenerative medicine.Background: Osteoarthritis (OA) is a common disease which usually occurs in middle-aged and elderly people. Hyaluronic acid (HA) has been widely used to treat OA and related researches on the efficacy and safety of HA in the treatment of OA have been published. Therefore, the purpose of this research was to investigate the subject characteristics of harnessing HA for the treatment of OA and to analyse the relevant trends and hotspots by using a bibliometric approach. Methods: The articles published from 1 January 2002 to 31 December 2021 were searched in the Web of Science Core Collection (WoSCC) and the relevant information of HA for the treatment of OA was extracted after screening. Then, a total of 2438 publications were analysed by using Microsoft Excel, CiteSpace 5.8.R3, VOSviewer 1.6.18 and the Online Analysis Platform of Literature Metrology (http://bibliometric.com/). Results: A total of 2438 articles were finally included for analysis. The number of publications increased year by year. A total of 83 coutries and 3319 institutions published 2438 manuscripts in the field of use HA for the treatment of OA. The most productive country was United States with total 689 publications and League of European Research Universities Leru (Belgium) was the leading institution with total 126 publicatios. In terms of authors, the most prominent author was KrausVB, who published 28 papers with the highest H-index (19). In addition, Osteoarthritis and Cartilage had the highest number of publications (152 articles) and the highest number of citations (6450 citations). The co-cited references analysis indicated that the article published by McAlindon in 2014 had the most highest number of citations (91co-citations). What's more, most research hotspots focused on the efficacy and safety of HA, and regenerative medicine researches such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) have attracted more and more attentions of researchers. Conclusion: This study visually analyzed the historical evolution and future trends of HA for the treatment of OA, and discussed the research priorities. At present, there are still different views on the efficacy of HA for the treatment of OA. Gradually, research hotspots of this field have focused on the regenerative medicine. Background: Osteoarthritis (OA) is a common disease which usually occurs in middle-aged and elderly people. Hyaluronic acid (HA) has been widely used to treat OA and related researches on the efficacy and safety of HA in the treatment of OA have been published. Therefore, the purpose of this research was to investigate the subject characteristics of harnessing HA for the treatment of OA and to analyse the relevant trends and hotspots by using a bibliometric approach.Methods: The articles published from 1 January 2002 to 31 December 2021 were searched in the Web of Science Core Collection (WoSCC) and the relevant information of HA for the treatment of OA was extracted after screening. Then, a total of 2438 publications were analysed by using Microsoft Excel, CiteSpace 5.8.R3, VOSviewer 1.6.18 and the Online Analysis Platform of Literature Metrology (http://bibliometric.com/).Results: A total of 2438 articles were finally included for analysis. The number of publications increased year by year. A total of 83 coutries and 3319 institutions published 2438 manuscripts in the field of use HA for the treatment of OA. The most productive country was United States with total 689 publications and League of European Research Universities Leru (Belgium) was the leading institution with total 126 publicatios. In terms of authors, the most prominent author was KrausVB, who published 28 papers with the highest H-index (19). In addition, Osteoarthritis and Cartilage had the highest number of publications (152 articles) and the highest number of citations (6450 citations). The co-cited references analysis indicated that the article published by McAlindon in 2014 had the most highest number of citations (91co-citations). What’s more, most research hotspots focused on the efficacy and safety of HA, and regenerative medicine researches such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) have attracted more and more attentions of researchers.Conclusion: This study visually analyzed the historical evolution and future trends of HA for the treatment of OA, and discussed the research priorities. At present, there are still different views on the efficacy of HA for the treatment of OA. Gradually, research hotspots of this field have focused on the regenerative medicine. |
| Author | Lin, Miaoyuan Huang, Tianji Zhao, Runhan Huang, Yanran Luo, Xiaoji Xu, Jingtao Wang, Yuping Wu, Zhillin Li, Zefang Zhang, Jun |
| AuthorAffiliation | 1 Department of Orthopedics , The First Affiliated Hospital of Chongqing Medical University , Orthopedic Laboratory of Chongqing Medical University , Chongqing , China 2 Department of Orthopedics , The Affiliated Hospital of Zunyi Medical University , Zunyi , China 4 Department of Orthopedics , Qianjiang Central Hospital of Chongqing , Chongqing , China 3 Department of Orthopedics , Dazhou Central Hospital of Sichuan , Dazhou , China |
| AuthorAffiliation_xml | – name: 3 Department of Orthopedics , Dazhou Central Hospital of Sichuan , Dazhou , China – name: 2 Department of Orthopedics , The Affiliated Hospital of Zunyi Medical University , Zunyi , China – name: 4 Department of Orthopedics , Qianjiang Central Hospital of Chongqing , Chongqing , China – name: 1 Department of Orthopedics , The First Affiliated Hospital of Chongqing Medical University , Orthopedic Laboratory of Chongqing Medical University , Chongqing , China |
| Author_xml | – sequence: 1 givenname: Jun surname: Zhang fullname: Zhang, Jun – sequence: 2 givenname: Miaoyuan surname: Lin fullname: Lin, Miaoyuan – sequence: 3 givenname: Yanran surname: Huang fullname: Huang, Yanran – sequence: 4 givenname: Yuping surname: Wang fullname: Wang, Yuping – sequence: 5 givenname: Tianji surname: Huang fullname: Huang, Tianji – sequence: 6 givenname: Zhillin surname: Wu fullname: Wu, Zhillin – sequence: 7 givenname: Zefang surname: Li fullname: Li, Zefang – sequence: 8 givenname: Jingtao surname: Xu fullname: Xu, Jingtao – sequence: 9 givenname: Runhan surname: Zhao fullname: Zhao, Runhan – sequence: 10 givenname: Xiaoji surname: Luo fullname: Luo, Xiaoji |
| BookMark | eNp1kl9rFDEUxQepYK39AL4N-OLLrvk_iQ9CKWoLBV8UH8NN5mY3y8ykJllhv73ZbgVb8OmG5JxfcsJ53Z0tacGue0vJmnNtPgQXE64ZYWxtFBXSvOjOGTNqJaiWZ_-sX3WXpewIIZTJQWp23v28gbxgKXHZ9NsDTPucluh78HHsQ8p93WJfM0Kdcal9Cn0qFRPkus2xxvKxv-pddFNMM9Z8NC4wHUosb7qXAaaCl4_zovvx5fP365vV3bevt9dXdysvBlJXKAwFxkGN4LVTfuTeSEWcIIIHqbWUDFExDVTo4CWOjAQqKXGcMCK94hfd7Yk7JtjZ-xxnyAebINqHjZQ3tj02-gkteKUGRyTXQQkF2vGA3hsIog3qhsb6dGLd792Mo2-JM0xPoE9Plri1m_TbGknVoHQDvH8E5PRrj6XaORaP0wQLpn2xbGDEMNlCNem7Z9Jd2uf2ecVyNnCihaSmqYaTyudUSsZgfaxQYzreHydLiT0WwD4UwB4LYE8FaE76zPk3xv89fwBfwbhb |
| CitedBy_id | crossref_primary_10_4103_jioh_jioh_147_24 crossref_primary_10_3389_fcell_2025_1552727 crossref_primary_10_1097_MD_0000000000038730 crossref_primary_10_3389_fphys_2022_1095868 crossref_primary_10_1097_MD_0000000000035854 crossref_primary_10_1080_14728222_2024_2416961 crossref_primary_10_1007_s40674_023_00207_x crossref_primary_10_1007_s11255_024_04081_x crossref_primary_10_3389_fbioe_2023_1301430 |
| Cites_doi | 10.1016/j.joca.2019.06.011 10.2106/00004623-200403000-00012 10.1038/s41598-020-67730-y 10.1002/acr.23204 10.1016/j.joca.2014.01.003 10.18632/aging.101713 10.3389/fphar.2021.637904 10.1016/j.biopha.2018.11.099 10.1097/01.blo.0000144483.62033.8b 10.1007/s11926-015-0525-0 10.1186/s13018-019-1352-1 10.1016/j.arthro.2017.11.035 10.3389/fmed.2021.787228 10.1007/s00167-015-3705-6 10.1016/j.jconrel.2022.03.031 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P 10.1002/sctm.18-0122 10.7326/0003-4819-157-3-201208070-00473 10.1186/s13075-019-1923-x 10.5966/sctm.2015-0245 10.4103/ijo.ijo_1349_21 10.21037/apm-21-2144 10.1016/j.biomaterials.2014.07.058 10.1007/s00402-019-03140-8 10.3390/ijms22115711 10.1016/j.arthro.2015.03.030 10.1002/jor.20683 10.1177/19476035211021903 10.1016/j.arthro.2021.02.045 10.1136/ard.2003.011742 10.1016/j.arthro.2011.05.011 10.1002/msc.1538 10.2106/00004623-200207000-00008 10.2217/rme-2018-0161 10.1016/j.arthro.2018.06.035 10.1126/sciadv.abl6449 10.1186/ar623 10.1177/1947603519888783 10.1016/j.semarthrit.2015.04.013 10.1016/j.ajp.2021.102846 10.7326/m14-1231 10.1177/0363546515582027 10.1002/adfm.202107678 10.4137/cmamd.s17894 10.1080/14712598.2020.1798925 10.1016/j.joca.2007.12.013 10.1177/0363546518814532 10.1016/j.joca.2018.01.010 10.1016/j.jcyt.2018.08.005 10.1177/19476035211025815 10.1002/art.41142 10.1111/jocd.12237 10.1177/0363546516665809 10.1177/1947603516684588 10.1016/j.joca.2021.03.006 |
| ContentType | Journal Article |
| Copyright | 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2022 Zhang, Lin, Huang, Wang, Huang, Wu, Li, Xu, Zhao and Luo. Copyright © 2022 Zhang, Lin, Huang, Wang, Huang, Wu, Li, Xu, Zhao and Luo. 2022 Zhang, Lin, Huang, Wang, Huang, Wu, Li, Xu, Zhao and Luo |
| Copyright_xml | – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2022 Zhang, Lin, Huang, Wang, Huang, Wu, Li, Xu, Zhao and Luo. – notice: Copyright © 2022 Zhang, Lin, Huang, Wang, Huang, Wu, Li, Xu, Zhao and Luo. 2022 Zhang, Lin, Huang, Wang, Huang, Wu, Li, Xu, Zhao and Luo |
| DBID | AAYXX CITATION 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.3389/fbioe.2022.961459 |
| DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College Coronavirus Research Database ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Engineering |
| DocumentTitleAlternate | Zhang et al |
| EISSN | 2296-4185 |
| ExternalDocumentID | oai_doaj_org_article_ac667b0538f646a8b3fecc9af4ecc1b7 PMC9516768 10_3389_fbioe_2022_961459 |
| GeographicLocations | Italy United States--US China Japan |
| GeographicLocations_xml | – name: China – name: United States--US – name: Italy – name: Japan |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAYXX ACGFS ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GNUQQ HCIFZ K9. LK8 M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c470t-e491a23a6dac8b6cd3c9560b4043f588552ee628a148fc5ed20f1510b30205c63 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 13 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000861996500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2296-4185 |
| IngestDate | Fri Oct 03 12:53:36 EDT 2025 Tue Sep 30 17:19:02 EDT 2025 Thu Sep 04 19:32:18 EDT 2025 Mon Nov 24 22:11:45 EST 2025 Sat Nov 29 05:42:55 EST 2025 Tue Nov 18 22:32:21 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c470t-e491a23a6dac8b6cd3c9560b4043f588552ee628a148fc5ed20f1510b30205c63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Jay Trivedi, Rhode Island Hospital, United States Reviewed by: Annunziata Mauro, University of Teramo, Italy These authors share first authorship This article was submitted to Tissue Engineering and Regenerative Medicine, a section of the journal Frontiers in Bioengineering and Biotechnology Edited by: Tim B. F. Woodfield, University of Otago, New Zealand |
| OpenAccessLink | https://www.proquest.com/docview/3273084519?pq-origsite=%requestingapplication% |
| PQID | 3273084519 |
| PQPubID | 7426804 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_ac667b0538f646a8b3fecc9af4ecc1b7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9516768 proquest_miscellaneous_2720925552 proquest_journals_3273084519 crossref_citationtrail_10_3389_fbioe_2022_961459 crossref_primary_10_3389_fbioe_2022_961459 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-09-09 |
| PublicationDateYYYYMMDD | 2022-09-09 |
| PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-09 day: 09 |
| PublicationDecade | 2020 |
| PublicationPlace | Lausanne |
| PublicationPlace_xml | – name: Lausanne |
| PublicationTitle | Frontiers in bioengineering and biotechnology |
| PublicationYear | 2022 |
| Publisher | Frontiers Media SA Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media SA – name: Frontiers Media S.A |
| References | Cooper (B13) 2017; 69 Jordan (B22) 2003; 62 Salwowska (B48) 2016; 15 Li (B32) 2015; 17 Campbell (B6) 2015; 31 Kim (B25) 2019; 139 Lin (B33) 2021; 2107678 Louis (B35) 2018; 34 Gurnani (B19) 2021; 69 Miller (B37) 2021; 13 (B46) 2000; 43 Filardo (B17) 2015; 43 Lee (B24); 8 Shah (B49) 2019; 14 Kon (B28) 2011; 27 Chen (B8) 2014; 35 Kolasinski (B26) 2019; 72 Lin (B34) 2019; 35 Raposo (B45) 2021; 19 Altman (B2) 2015; 45 Kon (B27) 2020; 20 Zacharjasz (B56) 2021; 22 Chen (B7) 2002; 84 Peng (B42) 2022; 345 Tan (B50) 2021; 10 Rutjes (B47) 2012; 157 Wu (B55) 2021; 13 Di Martino (B15) 2019; 47 Bannuru (B4) 2019; 27 Dan (B14) 2018; 26 Chiou (B10) 2018; 10 Lei (B30) 2021; 2105084 Karimi (B23) 2018; 20 Moreland (B40) 2003; 5 Wu (B54) 2021; 8 Moreland (B39) 2003; 5 Cole (B12) 2017; 45 Lei (B31) 2021; 8 Chen (B9) 2021; 65 Wang (B52) 2019; 13 Felson (B16) 2021; 29 McAlindon (B36) 2014; 22 Tenti (B51) 2021; 12 Raeissadat (B44) 2015; 8 Wang (B53) 2004; 86 Görmeli (B18) 2017; 25 Zhou (B58) 2010; 26 Haraden (B21) 2019; 21 Pullig (B43) 2016; 5 Chou (B11) 2020; 10 Lee (B29); 14 Mix (B38) 2004; 427 Ong (B41) 2021; 13 Zhang (B57) 2008; 16 Altman (B1) 2018; 9 Han (B20) 2021; 37 Harrell (B3) 2019; 109 Bannuru (B5) 2015; 162 |
| References_xml | – volume: 27 start-page: 1578 year: 2019 ident: B4 article-title: OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis publication-title: Osteoarthr. Cartil. doi: 10.1016/j.joca.2019.06.011 – volume: 86 start-page: 538 year: 2004 ident: B53 article-title: Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials publication-title: J. Bone Jt. Surg. doi: 10.2106/00004623-200403000-00012 – volume: 10 start-page: 10868 year: 2020 ident: B11 article-title: Synovial cell cross-talk with cartilage plays a major role in the pathogenesis of osteoarthritis publication-title: Sci. Rep. doi: 10.1038/s41598-020-67730-y – volume: 69 start-page: 1287 year: 2017 ident: B13 article-title: Use of intraarticular hyaluronic acid in the management of knee osteoarthritis in clinical practice publication-title: Arthritis Care Res. Hob. doi: 10.1002/acr.23204 – volume: 22 start-page: 363 year: 2014 ident: B36 article-title: OARSI guidelines for the non-surgical management of knee osteoarthritis publication-title: Osteoarthr. Cartil. doi: 10.1016/j.joca.2014.01.003 – volume: 10 start-page: 4152 year: 2018 ident: B10 article-title: Mechanistic insight into hyaluronicacid and platelet-rich plasma-mediated antiinflammatory and anti-apoptoticactivities in osteoarthritic mice publication-title: Aging doi: 10.18632/aging.101713 – volume: 12 start-page: 637904 year: 2021 ident: B51 article-title: New trends in injection-based therapy for thumb-base osteoarthritis: Where are we and where are we going? publication-title: Front. Pharmacol. doi: 10.3389/fphar.2021.637904 – volume: 109 start-page: 2318 year: 2019 ident: B3 article-title: Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2018.11.099 – volume: 427 start-page: S129 year: 2004 ident: B38 article-title: Novel inhibitors of matrix metalloproteinase gene expression as potential therapies for arthritis publication-title: Clin. Orthop. Relat. Res. doi: 10.1097/01.blo.0000144483.62033.8b – volume: 17 start-page: 49 year: 2015 ident: B32 article-title: RS3PE: Clinical and research development publication-title: Curr. Rheumatol. Rep. doi: 10.1007/s11926-015-0525-0 – volume: 14 start-page: 314 ident: B29 article-title: A placebo-controlled study comparing the efficacy of intra-articular injections of hyaluronic acid and a novel hyaluronic acid-platelet-rich plasma conjugate in a canine model of osteoarthritis publication-title: J. Orthop. Surg. Res. doi: 10.1186/s13018-019-1352-1 – volume: 34 start-page: 1530 year: 2018 ident: B35 article-title: Growth factors levels determine efficacy of platelets rich plasma injection in knee osteoarthritis: A randomized double blind noninferiority trial compared with viscosupplementation publication-title: Arthrosc. J. Arthrosc. Relat. Surg. doi: 10.1016/j.arthro.2017.11.035 – volume: 8 start-page: 787228 year: 2021 ident: B54 article-title: Mapping knowledge structure and themes trends of osteoporosis in rheumatoid arthritis: A bibliometric analysis publication-title: Front. Med. doi: 10.3389/fmed.2021.787228 – volume: 25 start-page: 958 year: 2017 ident: B18 article-title: Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: A randomized, double-blind, placebo-controlled trial publication-title: Knee Surg. Sports Traumatol. Arthrosc. doi: 10.1007/s00167-015-3705-6 – volume: 345 start-page: 625 year: 2022 ident: B42 article-title: Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020 publication-title: J. Control. Release doi: 10.1016/j.jconrel.2022.03.031 – volume: 43 start-page: 1905 year: 2000 ident: B46 article-title: Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of rheumatology subcommittee on osteoarthritis guidelines publication-title: Arthritis Rheum. doi: 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P – volume: 8 start-page: 504 ident: B24 article-title: Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: A phase IIb, randomized, placebo-controlled clinical trial publication-title: Stem Cells Transl. Med. doi: 10.1002/sctm.18-0122 – volume: 157 start-page: 180 year: 2012 ident: B47 article-title: Viscosupplementation for osteoarthritis of the knee: A systematic review and meta-analysis publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-157-3-201208070-00473 – volume: 21 start-page: 146 year: 2019 ident: B21 article-title: Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation publication-title: Arthritis Res. Ther. doi: 10.1186/s13075-019-1923-x – volume: 5 start-page: 847 year: 2016 ident: B43 article-title: Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: A phase I dose-escalation trial publication-title: Stem Cells Transl. Med. doi: 10.5966/sctm.2015-0245 – volume: 69 start-page: 2876 year: 2021 ident: B19 article-title: Altimetric, bibliometrics, citation indices, download counts, Eigen factor - the ABCDE science of research and publication publication-title: Indian J. Ophthalmol. doi: 10.4103/ijo.ijo_1349_21 – volume: 13 start-page: 124 year: 2019 ident: B52 article-title: Expert consensus on stepped treatment of knee osteoarthritis (2018 edition) publication-title: Chin. J. Jt. Surg. Electron. Ed. – volume: 10 start-page: 9136 year: 2021 ident: B50 article-title: The relationship between muscular atrophy/sarcopenia and cardiovascular diseases in the elderly: A bibliometrics study publication-title: Ann. Palliat. Med. doi: 10.21037/apm-21-2144 – volume: 35 start-page: 9599 year: 2014 ident: B8 article-title: Synergistic anabolic actions of hyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritis therapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.07.058 – volume: 139 start-page: 971 year: 2019 ident: B25 article-title: Intra-articular injection of mesenchymal stem cells for clinical outcomes and cartilage repair in osteoarthritis of the knee: A meta-analysis of randomized controlled trials publication-title: Arch. Orthop. Trauma Surg. doi: 10.1007/s00402-019-03140-8 – volume: 22 start-page: 5711 year: 2021 ident: B56 article-title: Small noncoding RNAs in knee osteoarthritis: The role of MicroRNAs and tRNA-derived fragments publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22115711 – volume: 31 start-page: 2036 year: 2015 ident: B6 article-title: Is local viscosupplementation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: A systematic review of overlapping meta-analyses publication-title: Arthrosc. J. Arthrosc. Relat. Surg. doi: 10.1016/j.arthro.2015.03.030 – volume: 26 start-page: 1643 year: 2010 ident: B58 article-title: The effect of hyaluronic acid on IL-1β-induced chondrocyte apoptosis in a rat model of osteoarthritis publication-title: J. Orthop. Res. doi: 10.1002/jor.20683 – volume: 13 start-page: 169s year: 2021 ident: B55 article-title: Molecular weight of hyaluronic acid has major influence on its efficacy and safety for viscosupplementation in hip osteoarthritis: A systematic review and meta-analysis publication-title: Cartilage doi: 10.1177/19476035211021903 – volume: 37 start-page: 2298 year: 2021 ident: B20 article-title: Intra-articular injections of platelet-rich plasma, adipose mesenchymal stem cells, and bone marrow mesenchymal stem cells associated with better outcomes than hyaluronic acid and saline in knee osteoarthritis: A systematic review and network meta-analysis publication-title: Arthroscopy doi: 10.1016/j.arthro.2021.02.045 – volume: 62 start-page: 1145 year: 2003 ident: B22 article-title: EULAR recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT) publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2003.011742 – volume: 27 start-page: 1490 year: 2011 ident: B28 article-title: Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis publication-title: Arthrosc. J. Arthrosc. Relat. Surg. doi: 10.1016/j.arthro.2011.05.011 – volume: 19 start-page: 399 year: 2021 ident: B45 article-title: Effects of exercise on knee osteoarthritis: A systematic review publication-title: Musculoskelet. Care doi: 10.1002/msc.1538 – volume: 84 start-page: 1142 year: 2002 ident: B7 article-title: Granulomatous inflammation after hylan G-F 20 viscosupplementation of the knee : A report of six cases publication-title: J. Bone Jt. Surg. doi: 10.2106/00004623-200207000-00008 – volume: 14 start-page: 213 year: 2019 ident: B49 article-title: Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: A randomized controlled trial publication-title: Regen. Med. doi: 10.2217/rme-2018-0161 – volume: 35 start-page: 106 year: 2019 ident: B34 article-title: Intra-articular injection of platelet-rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis: A randomized, double-blind, triple-parallel, placebo-controlled clinical trial publication-title: Arthrosc. J. Arthrosc. Relat. Surg. doi: 10.1016/j.arthro.2018.06.035 – volume: 8 start-page: 1 year: 2021 ident: B31 article-title: Injectable hydrogel microspheres withself-renewable hydration layers alleviate osteoarthritis publication-title: Sci. Adv. doi: 10.1126/sciadv.abl6449 – volume: 5 start-page: 54 year: 2003 ident: B39 article-title: Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: Mechanisms of action publication-title: Arthritis Res. Ther. doi: 10.1186/ar623 – volume: 13 start-page: 351s year: 2021 ident: B37 article-title: Safety of intra-articular hyaluronic acid for knee osteoarthritis: Systematic review and meta-analysis of randomized trials involving more than 8, 000 patients publication-title: Cartilage doi: 10.1177/1947603519888783 – volume: 45 start-page: 132 year: 2015 ident: B2 article-title: Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid publication-title: Semin. Arthritis Rheum. doi: 10.1016/j.semarthrit.2015.04.013 – volume: 65 start-page: 102846 year: 2021 ident: B9 article-title: Bibliometric analysis of mental health during the COVID-19 pandemic publication-title: Asian J. Psychiatr. doi: 10.1016/j.ajp.2021.102846 – volume: 162 start-page: 46 year: 2015 ident: B5 article-title: Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: A systematic review and network meta-analysis publication-title: Ann. Intern. Med. doi: 10.7326/m14-1231 – volume: 43 start-page: 1575 year: 2015 ident: B17 article-title: Platelet-rich plasma intra-articular knee injections Show No superiority versus viscosupplementation: A randomized controlled trial publication-title: Am. J. Sports Med. doi: 10.1177/0363546515582027 – volume: 5 start-page: 54 year: 2003 ident: B40 article-title: Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: Mechanisms of action publication-title: Arthritis Res. Ther. doi: 10.1186/ar623 – volume: 2107678 start-page: 1 year: 2021 ident: B33 article-title: Charge-guided micro/nano-hydrogel microsphere for penetrating cartilage matrix publication-title: Adv. Funct. Mater doi: 10.1002/adfm.202107678 – volume: 8 start-page: CMAMD.S17894 year: 2015 ident: B44 article-title: Knee osteoarthritis injection Choices: Platelet- rich plasma (PRP) versus hyaluronic acid (A one-year randomized clinical trial) publication-title: Clin. Med Insights Arthritis Musculoskelet. Disord. doi: 10.4137/cmamd.s17894 – volume: 20 start-page: 1447 year: 2020 ident: B27 article-title: Platelet-rich plasma for the treatment of knee osteoarthritis: An expert opinion and proposal for a novel classification and coding system publication-title: Expert Opin. Biol. Ther. doi: 10.1080/14712598.2020.1798925 – volume: 16 start-page: 137 year: 2008 ident: B57 article-title: OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines publication-title: Osteoarthr. Cartil. doi: 10.1016/j.joca.2007.12.013 – volume: 47 start-page: 347 year: 2019 ident: B15 article-title: Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis: Results at 5 Years of a double-blind, randomized controlled trial publication-title: Am. J. Sports Med. doi: 10.1177/0363546518814532 – volume: 26 start-page: 445 year: 2018 ident: B14 article-title: Intra-articular injection of mesenchymal stem cells in treating knee osteoarthritis: A systematic review of animal studies-ScienceDirect publication-title: Osteoarthr. Cartil. doi: 10.1016/j.joca.2018.01.010 – volume: 20 start-page: 1238 year: 2018 ident: B23 article-title: Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis:a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial publication-title: Cytotherapy doi: 10.1016/j.jcyt.2018.08.005 – volume: 13 start-page: 376s year: 2021 ident: B41 article-title: Risk of severe acute localized reactions for different intraarticular hyaluronic acid knee injections in a real-world setting publication-title: Cartilage doi: 10.1177/19476035211025815 – volume: 72 start-page: 220 year: 2019 ident: B26 article-title: 2019 American College of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee publication-title: Arthritis Rheumatol. doi: 10.1002/art.41142 – volume: 2105084 start-page: 1 year: 2021 ident: B30 article-title: Stem cell-recruiting injectable microgels for repairing osteoarthritis, 2021 for repairing osteoarthritis publication-title: Adv. Funct. Mater – volume: 15 start-page: 520 year: 2016 ident: B48 article-title: Physiochemical properties and application of hyaluronic acid: A systematic review publication-title: J. Cosmet. Dermatol. doi: 10.1111/jocd.12237 – volume: 45 start-page: 339 year: 2017 ident: B12 article-title: Hyaluronic acid versus platelet-rich plasma: A prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis publication-title: Am. J. Sports Med. doi: 10.1177/0363546516665809 – volume: 9 start-page: 11 year: 2018 ident: B1 article-title: Review of the mechanism of action for Supartz FX in knee osteoarthritis publication-title: Cartilage doi: 10.1177/1947603516684588 – volume: 29 start-page: 973 year: 2021 ident: B16 article-title: Fatty acids and osteoarthritis: The MOST study publication-title: Osteoarthr. Cartil. doi: 10.1016/j.joca.2021.03.006 |
| SSID | ssj0001257582 |
| Score | 2.2826817 |
| Snippet | Background:
Osteoarthritis (OA) is a common disease which usually occurs in middle-aged and elderly people. Hyaluronic acid (HA) has been widely used to treat... Background: Osteoarthritis (OA) is a common disease which usually occurs in middle-aged and elderly people. Hyaluronic acid (HA) has been widely used to treat... |
| SourceID | doaj pubmedcentral proquest crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | 961459 |
| SubjectTerms | Arthritis Bibliometrics Bioengineering and Biotechnology Cartilage Cartilage diseases Citations Cooperation Data collection Hirsch index Hyaluranic acid Hyaluronic acid Hyperplasia Mesenchymal stem cells Molecular weight Osteoarthritis Regenerative medicine Research hot spots Trends Viscosity |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEB1K6CE5lDYf1ElaVOip4MSrL8u9pSUhp9BDS3MTkiyxC4tdNtlC_31mZGexL-2lJ2NLxtJoJL1njZ4APhJFCCLWZXIhllIi3fFKyHIhfLNoBY6G3OfDJuq7O3N_33ybHPVFMWGDPPBguEsXtK49uopJWmpnvEj41cYliZeFz_vIEfVMyNTwdwVhiOHDMiaysOYy-VVPspicXzQ4JZE26WQiynr9M5A5D5GczDk3r-HVCBbZ1VDIN_AidodwMJEQPIKft25DoxXesOUft95mrVvmwqpliEcZ4ju2CyZnfWK0qaPHai-zmtFndsX8yq9pEz5p9TM3ipQcw4-b6-9fb8vxsIQyyLp6LKNsFo4Lp1sXjNehFYGojyf1nKSMUYrHqLlxyH9SULHlVcLZvvICAaMKWpzAXtd38S0wV8uk2haRjxcyGOV1zXlqlXdeSWzTAqpny9kwKonTgRZri4yCjG2zsS0Z2w7GLuDT7pVfg4zG3zJ_oebYZSQF7PwA_cKOfmH_5RcFnD83ph275YMVCNYqQ4o6BXzYJWOHolUS18V--2BpYbpBoqV4AfXMCWYFmqd0q2WW5ka8qpHAnf6PGpzBPhklB7Q157D3uNnGd_Ay_Ebv2LzP_v4E_t0KAQ priority: 102 providerName: Directory of Open Access Journals |
| Title | Harnessing hyaluronic acid for the treatment of osteoarthritis: A bibliometric analysis |
| URI | https://www.proquest.com/docview/3273084519 https://www.proquest.com/docview/2720925552 https://pubmed.ncbi.nlm.nih.gov/PMC9516768 https://doaj.org/article/ac667b0538f646a8b3fecc9af4ecc1b7 |
| Volume | 10 |
| WOSCitedRecordID | wos000861996500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2296-4185 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001257582 issn: 2296-4185 databaseCode: DOA dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2296-4185 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001257582 issn: 2296-4185 databaseCode: M~E dateStart: 20130101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2296-4185 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001257582 issn: 2296-4185 databaseCode: M7P dateStart: 20220101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2296-4185 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001257582 issn: 2296-4185 databaseCode: 7X7 dateStart: 20220101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2296-4185 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001257582 issn: 2296-4185 databaseCode: BENPR dateStart: 20220101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2296-4185 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001257582 issn: 2296-4185 databaseCode: PIMPY dateStart: 20220101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9MwFLfYxgEOfCMCozISJ6Sw1h-xwwVtqNM4UEUIRDlZtmPTSlWyteskLvztvOempbnswiVRYkdx8p6ff89-_j1C3qKL4HlQebQ-5EKAu-MkF_mIu3JUc7CGzKVkE2oy0dNpWXUTbqsurHJrE5OhrluPc-QnHMbZoUYylI-XVzlmjcLV1S6FxgE5QpYEnkL3qr05FgAjmm0WM8EXK0-im7dIjsnY-xIGJmQo3RuOEmt_D2r2AyX3Rp7zh__b5kfkQYc56elGSR6TO6F5Qu7vMRE-JT8u7BKNHlzQ2W-7WCfKXGr9vKYAaynARLqLSadtpLg3pAW1myVSpA_0lLq5W-BefqT8p7bjOnlGvp-Pv326yLucC7kXanidB1GOLOO2qK3XrvA19-hBOSThiVJrKVkIBdMW3KjoZajZMAJoGDoOuFP6gj8nh03bhBeEWiWirGsAUI4Lr6UrFGOxls46KUA1MjLc_nrjO0JyzIuxMOCYoLRMkpZBaZmNtDLybvfI5YaN47bKZyjPXUUk0k432uUv0_VLY31RKAeWSMdCFFY7HkGpSxsFnEZOZeR4K1rT9e6V-SfXjLzZFUO_xMUW24R2vTK4vl2CvyZZRlRPi3oN6pc081li-AbYW4Af-PL2l78i9_BzU8RbeUwOr5fr8Jrc9Tcg9-WAHKipSkc9IEdn40n1dZBmHAapk-DxzxhKqs9fqp9_AX_JHbk |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9NAEB2VggQc-EYNFFgkuCCZOrtee42EUPmoUrVEPRTR27K73iWRorhNGlD_FL-RmbUdkktvPXCyYjuxHb-dec87fgPwiiSCE75IgnE-yTKUO1aKLOkLW_YrgdGQ29hsohgO1clJebQBf7p3YaissouJMVBXtaNn5DsC82yqyAzlw-lZQl2jaHa1a6HRwOLAX_xGyTZ_v_8Z7-9rzve-HH8aJG1XgcRlRXqe-KzsGy5MXhmnbO4q4UgjWLKZCVIpKbn3OVcGhUJw0lc8DZgWUyuQWUmXC_zda3AdaQRXsVTwaOWZDpIfxZvJU9R-5U6w45rMODl_W2IiJEfUlfQXuwSsUdv1wsyVTLd393_7j-7BnZZTs91mENyHDT99ALdXnBYfwveBmVFQxw9sdGEmi2gJzIwbVwxpO0MazJY196wOjN59qXFYjaLp0zu2y-zYTsirgFoaMNN6uTyCb1dyZY9hc1pP_RYwU2RBVhUSRCsyp6TNC85DJa2xMkPo9yDtbrV2reE69f2YaBRehA4d0aEJHbpBRw_eLL9y2riNXLbzR8LPckcyCo8r6tlP3cYdbVyeFxYjrQp5lhtlRcBBW5qQ4aJvix5sd1DSbfSa63846sHL5WaMOzSZZKa-Xsw1zd-XqEcl70Gxhtq1E1rfMh2PooM50vocde6Tyw_-Am4Ojr8e6sP94cFTuEWXHqv7ym3YPJ8t_DO44X4hBmbP4zBk8OOqMf0XVdtxtg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Harnessing+hyaluronic+acid+for+the+treatment+of+osteoarthritis%3A+A+bibliometric+analysis&rft.jtitle=Frontiers+in+bioengineering+and+biotechnology&rft.au=Zhang%2C+Jun&rft.au=Lin%2C+Miaoyuan&rft.au=Huang%2C+Yanran&rft.au=Wang%2C+Yuping&rft.date=2022-09-09&rft.pub=Frontiers+Media+S.A&rft.eissn=2296-4185&rft.volume=10&rft_id=info:doi/10.3389%2Ffbioe.2022.961459&rft.externalDocID=PMC9516768 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-4185&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-4185&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-4185&client=summon |